Statistics
Publications
193
Citations
23.5K
H-Index
78
Active since
1983
Kevan C. Herold is an author at Yale University specializing in immunology, life sciences, and diabetes mellitus.
Publications per year
1983–2025
193
193
Anti-CD3 Monoclonal Antibody in New-Onset Type 1 Diabetes Mellitus
Kevan C. Herold, William Hagopian, Julie Auger et al. · New England Journal of Medicine · 2002 · 1.2K citations · Full text
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
Kevan C. Herold, Brian N. Bundy, S. Alice Long et al. · New England Journal of Medicine · 2019 · 1.1K citations · Full text
Type 1 diabetes immunotherapy using polyclonal regulatory T cells
Jeffrey A. Bluestone, Jane H. Buckner, Mark Fitch et al. · Science Translational Medicine · 2015 · 1K citations
Reprogramming human T cell function and specificity with non-viral genome targeting
Theodore L. Roth, Cristina Puig-Saus, Ruby Yu et al. · Nature · 2018 · 853 citations · Full text
Control of TH17 cells occurs in the small intestine
Enric Esplugues, Samuel Huber, Nicola Gagliani et al. · Nature · 2011 · 652 citations
1–5 of 193